drugset / Trial / NCT03566134
A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Therapeutic Exploratory Clinical Study to evaluate the efficacy and safety of DA-8010 in Patients with Overactive Bladder and to determine the optimal dose of DA-8010
Timeline
- Start
- 2018-07-10
- Primary completion
- 2019-12-27
- Completion
- 2019-12-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Solifenacin | Small molecule | 5 mg | Oral |
| Subject | VELUFENACIN | Small molecule | 2.5 mg | Oral |
| Subject | VELUFENACIN | Small molecule | 5 mg | Oral |